awmsg logo



methylnaltrexone bromide (Relistor®)


Reference No. 2798

Publication date:
13/10/2015


Appraisal information

methylnaltrexone bromide (Relistor®) 12 mg/0.6 ml solution for injection


Company: TMC Pharma Services Ltd
BNF category: Gastro-intestinal system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 09/10/2015

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, methylnaltrexone bromide (Relistor®) cannot be endorsed for use within NHS Wales for the treatment of opioid-induced constipation when response to laxative therapy has not been sufficient in adult patients aged 18 years and older.
Statement of Advice (SOA)
Download